Genscript Biotech Reports 2022 Interim Results* ...Middle East

Segment Revenue and Profit Grew Steadily Gene and Cell Therapy CDMO Maintained High Growth Trend Revenue of the Group for the six months ended June 30, 2022 was approximately US$304.7 million, representing an increase of 32.7% as compared with approximately US$229.6 million for the same...

Read More Details
Finally We wish PressBee provided you with enough information of ( Genscript Biotech Reports 2022 Interim Results* )

Also on site :

• Vacaville carjacking suspects arrested in Fairfield; suspect shot by police
• UK government suspends free trade talks with Israel over Gaza war
• UK pauses trade negotiations with Israel and summons Israeli ambassador